{"url_path":"/register/2026-07-02/2026-13374","section_key":"summary","section_title":"Termination of Declaration Authorizing Emergency Use of Drug and Biological Products During the COVID-19 Pandemic","topic":"register","document":{"doc_type":"Notice","doc_date":"2026-07-02","source_url":"https://www.federalregister.gov/documents/2026/07/02/2026-13374/termination-of-declaration-authorizing-emergency-use-of-drug-and-biological-products-during-the","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Health and Human Services Department"},"word_count":199,"has_tables":false,"body_markdown":"# Termination of Declaration Authorizing Emergency Use of Drug and Biological Products During the COVID-19 Pandemic\n\n**Type:** Notice\n**Published:** 2026-07-02\n**Effective:** 2027-06-29\n**Citation:** 91 FR 40546\n**Agencies:** Health and Human Services Department\n**Source:** https://www.federalregister.gov/documents/2026/07/02/2026-13374/termination-of-declaration-authorizing-emergency-use-of-drug-and-biological-products-during-the\n\n## Abstract\nThe Secretary of Health and Human Services is issuing this notice pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act (FD&C) Act. On February 4, 2020, as amended on March 15, 2023, the HHS Secretary determined that there is a public health emergency, or significant potential for a public health emergency, that affects, or has a significant potential to affect, national security or the health and security of United States (U.S.) citizens living abroad, and that involves the virus (later referred to as SARS-CoV-2) that causes COVID- 19. Based on this determination, on March 27, 2020, the HHS Secretary declared that circumstances exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic. On June 29, 2026, the HHS Secretary determined that circumstances no longer exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic. Based on this determination, the HHS Secretary is terminating this declaration, effective on June 29, 2027."}